AIM ImmunoTech Inc.
AIM
$0.119
-$0.001-0.83%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -101.53% | 68.44% | 53.75% | -60.90% | -59.22% |
| Total Depreciation and Amortization | 3.28% | 5.17% | 0.00% | 9.43% | -33.75% |
| Total Amortization of Deferred Charges | -119.29% | 169.86% | -- | -- | -- |
| Total Other Non-Cash Items | -78.57% | 700.00% | -84.51% | 326.42% | 192.44% |
| Change in Net Operating Assets | 116.96% | -396.34% | -63.21% | 7.71% | -32.01% |
| Cash from Operations | -3.39% | 37.53% | 50.66% | -72.07% | -162.79% |
| Capital Expenditure | -- | -- | -- | 200.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 234.29% | -683.33% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -57.38% | 622.78% | 41.70% | 6.87% | -38.57% |
| Cash from Investing | -59.56% | 622.78% | 26.17% | 36.31% | -64.71% |
| Total Debt Issued | 200.00% | -105.32% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.24% | 60.18% | 123.81% | -36.91% | 4,560.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Financing | -94.39% | -13.72% | 1,824.49% | -36.91% | 4,560.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,118.92% | 112.08% | 78.18% | -70.16% | -144.97% |
